Skip to main content
Back
OPCH logo

Option Care Health, Inc.

Data quality: 100%
Oversold
OPCH
NASDAQ Healthcare Medical - Care Facilities
$28.49
▲ $0.08 (0.28%)
Mkt Cap: 4.52B
Day Range
$28.33 $28.79
52-Week Range
$24.24 $36.80
Volume
1,213,990
50D / 200D Avg
$33.13 / $30.45
Prev Close
$28.41

Quick Summary

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (631 peers)

Metric Stock Sector Median
P/E 21.8 0.2
P/B 3.4 3.0
ROE % 15.2 3.6
Net Margin % 3.7 3.8
Rev Growth 5Y % 13.2 9.9
D/E 0.0 0.2

Analyst Price Target

Hold
$38.14 +33.9%
Low: $35.00 High: $42.00
Forward P/E
15.25
Forward EPS
$1.87
EPS Growth (est.)
+0.0%
Est. Revenue
5.94B

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2030 $2.85
$2.80 – $2.90
 8.33B 1
FY2029 $2.58
$2.54 – $2.62
 7.66B 1
FY2028 $2.44
$2.44 – $2.45
 7.03B 3

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-24 $0.46 $0.46 0.0%
2025-10-30 $0.43 $0.45 +4.7%
2025-07-30 $0.40 $0.41 +2.5%
2025-04-29 $0.36 $0.40 +11.1%
2025-02-26 $0.33 $0.35 +6.1%
2024-10-30 $0.31 $0.31 0.0%
2024-07-31 $0.27 $0.30 +11.1%
2024-04-23 $0.23 $0.26 +13.0%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Key Takeaways

Revenue grew 13.22% annually over 5 years — strong growth
ROE of 15.20% — decent returns on equity
Debt/Equity of 0.00 — conservative balance sheet
Generating 258.45M in free cash flow
Cash machine — converts 124.50% of earnings into free cash flow
Capital efficient — spends only 0.00% of revenue on capex

Growth

Revenue Growth (5Y)
13.22%
Revenue (1Y)13.03%
Earnings (1Y)-2.00%
FCF Growth (3Y)-11.43%

Quality

Return on Equity
15.20%
ROIC19.11%
Net Margin3.67%
Op. Margin5.98%

Safety

Debt / Equity
0.00
Current Ratio1.53
Interest Coverage2.70

Valuation

P/E Ratio
21.79
Forward P/E15.25
P/B Ratio3.41
EV/EBITDA12.69
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 13.03% Revenue Growth (3Y) 14.59%
Earnings Growth (1Y) -2.00% Earnings Growth (3Y) -11.84%
Revenue Growth (5Y) 13.22% Earnings Growth (5Y) 10.37%
Profitability
Revenue (TTM) 5.65B Net Income (TTM) 207.59M
ROE 15.20% ROA 6.01%
Gross Margin 19.26% Operating Margin 5.98%
Net Margin 3.67% Free Cash Flow (TTM) 258.45M
ROIC 19.11% FCF Growth (3Y) -11.43%
Safety
Debt / Equity 0.00 Current Ratio 1.53
Interest Coverage 2.70
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 21.79 Forward P/E 15.25
P/B Ratio 3.41 P/S Ratio 0.80
PEG Ratio 5.98 Forward PEG N/A
EV/EBITDA 12.69 Fwd EV/EBITDA 8.42
Forward P/S 0.76 Fwd Earnings Yield 6.56%
FCF Yield 5.71%
Market Cap 4.52B Enterprise Value 4.29B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 5.65B 5.00B 4.30B 3.94B 3.44B
Net Income 207.59M 211.82M 267.09M 150.56M 139.90M
EPS (Diluted) 1.28 1.23 1.48 0.83 0.77
Gross Profit 1.09B 1.01B 981.22M 866.92M 779.61M
Operating Income 337.91M 321.83M 314.60M 240.23M 190.84M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 3.46B 3.42B 3.33B 3.23B 2.93B
Total Liabilities 2.13B 2.02B 1.91B 1.85B 1.75B
Shareholders' Equity 1.33B 1.40B 1.42B 1.39B 1.18B
Total Debt 0.0 1.22B 1.17B 1.16B 1.16B
Cash & Equivalents 232.62M 412.57M 343.85M 294.19M 119.42M
Current Assets 1.26B 1.32B 1.09B 994.34M 710.26M
Current Liabilities 829.35M 780.15M 618.31M 565.35M 459.70M

Strategy Scores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#994 of 1049
19
Growth Price/Sales Ratio Focus (Ken Fisher)
#369 of 619
30

Recent Activity

Entered Cash Flow Compounder
Mar 24, 2026
Entered Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026